Free tool
FAERS Monitor: Versacloz
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 203479 or its brand name (Versacloz, Clozapine). Reports on generic versions are filed under their own applications.
Reports
77,118
Serious
71,543
93% of reports
Hospitalization
31,030
Death reported
11,485
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- neutropenia16,561
- hospitalisation7,715
- death5,563
- drug ineffective3,193
- drug interaction2,832
- granulocytopenia2,567
- off label use2,157
- psychotic disorder1,915
- leukopenia1,747
- neutrophilia1,694
- agranulocytosis1,651
- toxicity to various agents1,639
- somnolence1,605
- sedation1,597
- schizophrenia1,578
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,168 |
| 2005 | 931 |
| 2006 | 2,035 |
| 2007 | 477 |
| 2008 | 441 |
| 2009 | 531 |
| 2010 | 1,063 |
| 2011 | 3,917 |
| 2012 | 1,657 |
| 2013 | 858 |
| 2014 | 926 |
| 2015 | 1,307 |
| 2016 | 3,401 |
| 2017 | 4,411 |
| 2018 | 3,864 |
| 2019 | 4,510 |
| 2020 | 4,796 |
| 2021 | 4,528 |
| 2022 | 10,809 |
| 2023 | 9,614 |
| 2024 | 8,031 |
| 2025 | 5,048 |
| 2026 | 2,793 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,977,041 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| granulocytopeniaSignal | 2,567 | 222.7 | 211.5 | 311,495 |
| neutrophiliaSignal | 1,694 | 115.2 | 108.9 | 134,674 |
| schizophreniaSignal | 1,578 | 40.6 | 38.5 | 52,971 |
| neutropeniaSignal | 16,561 | 37.7 | 37.1 | 522,776 |
| agranulocytosisSignal | 1,651 | 26.5 | 25.2 | 36,901 |
| psychotic disorderSignal | 1,915 | 18.8 | 18.0 | 30,291 |
| sedationSignal | 1,597 | 17.6 | 16.8 | 23,562 |
| hospitalisationSignal | 7,715 | 14.4 | 14.1 | 91,778 |
| leukopeniaSignal | 1,747 | 9.8 | 9.4 | 13,403 |
| drug interactionSignal | 2,832 | 4.9 | 4.8 | 8,800 |
| toxicity to various agentsSignal | 1,639 | 2.7 | 2.5 | 1,703 |
| somnolenceSignal | 1,605 | 2.2 | 2.1 | 1,030 |
| death | 5,563 | 1.8 | 1.7 | 1,914 |
| off label use | 2,157 | 0.7 | 0.6 | 362 |
| drug ineffective | 3,193 | 0.7 | 0.6 | 595 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.